Company Filing History:
Years Active: 2015-2020
Title: Stig Linder: Innovator in Pharmaceutical Compositions
Introduction
Stig Linder is a notable inventor based in Bromma, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for cancer treatment. With a total of 5 patents, Linder's work is recognized for its innovative approaches to complex medical challenges.
Latest Patents
Linder's latest patents include a pharmaceutical composition comprising indole derivatives. This invention provides well-defined and stable pharmaceutical compositions that include di-hydrochloride salts with a high content of the pharmacologically active isomer. These compositions are suitable for industrial production and are intended for use in treating cancer. Another significant patent focuses on the treatment of solid tumors using a cell-permeable iron chelator, which can be combined with an autophagy inhibiting agent. This method aims to enhance the effectiveness of cancer treatments by utilizing specific compounds that target cancer cells.
Career Highlights
Stig Linder is currently associated with Vivolux AB, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing treatment options for cancer patients, showcasing his commitment to improving healthcare outcomes.
Collaborations
Linder collaborates with notable colleagues such as Rolf Larsson and Mårten Fryknäs, contributing to a dynamic research environment focused on pharmaceutical advancements.
Conclusion
Stig Linder's contributions to pharmaceutical innovations, particularly in cancer treatment, highlight his role as a leading inventor in the field. His patents reflect a dedication to developing effective therapies that can significantly impact patient care.